LI
BNTX icon

LRI Investments’s BioNTech BNTX Stock Holding History

LRI Investments’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.9K Hold
160
– – ﹤0.01% 851
2026
Q1 		$14.2K Buy
160
+50
+45% +$5.14K ﹤0.01% 785
2025
Q4 		$10.5K Hold
110
– – ﹤0.01% 857
2025
Q3 		$10.8K Sell
110
-335
-75% -$35.8K ﹤0.01% 858
2025
Q2 		$47.4K Buy
445
+312
+235% +$31.5K ﹤0.01% 560
2025
Q1 		$12.2K Buy
133
+23
+21% +$2.58K ﹤0.01% 757
2024
Q4 		$12.5K Hold
110
– – ﹤0.01% 741
2024
Q3 		$11.4K Sell
110
-57
-34% -$5.24K ﹤0.01% 762
2024
Q2 		$13.4K Buy
167
+57
+52% +$5.21K ﹤0.01% 688
2024
Q1 		$10.1K Buy
+110
New +$10.5K ﹤0.01% 503

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

LRI Investments's BNTX Position: Q2 2026 in Review

LRI Investments held its BioNTech (BNTX) position steady in Q2 2026 at 160 shares worth $14.9K. The position accounts for ﹤0.01% of the portfolio, ranked #851.

LRI Investments first reported a position in BNTX in Q1 2024 and has held it in 10 quarters since. The position peaked at $47.4K in Q2 2025. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • LRI Investments held 160 shares of BioNTech worth $14.9K as of Q2 2026.
  • LRI Investments left its BioNTech share count unchanged in Q2 2026.
  • BioNTech made up ﹤0.01% of LRI Investments's portfolio in Q2 2026, its #851 holding.
  • LRI Investments first reported a position in BioNTech in Q1 2024 and has held it in 10 quarters since.
  • LRI Investments's BioNTech position peaked at $47.4K in Q2 2025.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.